Regulatory Strategies and Challenges for Neglected Infectious Diseases of High Medical Impact but Low Commercial Value: The Case of the Medicines for Malaria Venture 3 December 2001 The Regulatory Affairs Journal
GlaxoSmithKline and University of California at San Francisco to collaborate with Medicines for Malaria Venture on a joint project 11 October 2001
MMV Annual Report 2000 5 June 2001 Read an up-to-date overview of our activities and the financial statement for 2000.
ExxonMobil's first grant to MMV was announced at a special event held at Harvard School of Public Health 17 April 2001
